NIKI Stock Catalyst: Niki BioSolutions Enters Strategic Agreement with Progressive Medical Research

Jul 23, 2026 · 8:01am ET

Niki BioSolutions to provide APOE testing services for PMR.

Max move

+102.9%

High of day $17.85

Sparker timei

8:01am ET

NIKI · Jul 23, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Niki BioSolutions, Inc. (XNAS: NIKI) announced a strategic agreement with Progressive Medical Research (PMR) to provide APOE testing services. The agreement was finalized on the announcement date.

Under the terms of the agreement, Niki BioSolutions will offer its specialized APOE testing services to PMR, enhancing PMR's diagnostic capabilities. The collaboration aims to improve patient outcomes through advanced genetic testing.

Niki BioSolutions has 814,375 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time NIKI sparks.

Download Sniper App →

Catch the next NIKI-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

NIKI Stock Catalyst: Niki BioSolutions Enters Strategic Agreement with Progressive Medical Research

NIKI · Jul 23, 2026

NIKI · Jul 23, 2026

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.